Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01393873 · ClinicalTrials.gov registry record
Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01393873: Clinical Trial study, sponsored by NYU Langone Health.
NCT01393873 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01393873 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Studies conducted assessing diabetic eye disease have shown a progression of diabetic retinopathy with rapid improvement of glycemic control during pregnancy and in patients with type 1 diabetes. It is also well documented that bariatric surgery may result in rapid improvement of glycemic control in obese patients with type 2 diabetes. To our knowledge the progression of diabetic eye disease seen in pregnancy and type 1 diabetes has not been studied in obese type 2 diabetics undergoing bariatric surgery. To this end, this study will examine the effects of rapid glycemic control which is seen in type 2 diabetics following bariatric surgery on the progression of diabetic retinopathy.
Primary Outcome
whether rapid changes in the level of retinopathy do or do not occur in the transition period following surgery, where weight loss may be rapid causing improvement in insulin resistance and glycemic control.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-07 |
Why NCT01393873 stopped before completion
NCT01393873 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01393873 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01393873 about?
NCT01393873 is a clinical study titled "Progression of Diabetic Retinopathy Post Bariatric Surgery (BS)". Studies conducted assessing diabetic eye disease have shown a progression of diabetic retinopathy with rapid improvement of glycemic control during pregnancy and in patients with type 1 diabetes. It is also well documented that bariatric surgery may result in rapid improvement of glycemic control in...
What is the current status of trial NCT01393873?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2011-07. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT01393873?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia